9-Aminomethyl-9,10-dihydroanthracene
Chemical compound
From Wikipedia, the free encyclopedia
AMDA, also known as 9-aminomethyl-9,10-dihydroanthracene, is a tricyclic compound and cyclized phenethylamine which acts as a potent and selective antagonist for the 5-HT2A receptor (Ki = 20 nM).[1][2] It has been used to help study the shape of the 5-HT2A protein,[3] and develop a large family of related derivatives with even higher potency and/or selectivity.[4][5][6][7][8]

Other names9-Aminomethyl-9,10-dihydroanthracene
ATC code
- None
| Clinical data | |
|---|---|
| Other names | 9-Aminomethyl-9,10-dihydroanthracene |
| Drug class | Serotonin 5-HT2A receptor antagonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H15N |
| Molar mass | 209.292 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Another related compound is AMDH, in which the central cyclohexane ring of AMDA has instead been expanded into a cycloheptane ring.[1][9] As with AMDA, AMDH shows good affinity for the serotonin 5-HT2A receptor (Ki = 112 nM).[1]